Global Adoptive Cell Therapy Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 11-Feb-2020
No. of pages: 95
Inquire Before Buying

This report focuses on the global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.

The key players covered in this study

- Novartis

- Juno

- Kite

- Adaptimmune

- Fibrocell

- Lineage Cell Therapeutics

- BioTime

- Vericel Corporation

- Regeneus

- Anhui Anke Biotechnology

- Cellectis

- NantKwest

- SorrentoTherapeutics

- Bellicum

Market segment by Type, the product can be split into

- CAR-T

- TCR-T

- NK

- TIL

Market segment by Application, split into

- Lymphoma

- Leukemia

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- South Korea

- India

The study objectives of this report are:

- To analyze global Adoptive Cell Therapy status, future forecast, growth opportunity, key market and key players.

- To present the Adoptive Cell Therapy development in North America, Europe, China, Japan, South Korea and India.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Adoptive Cell Therapy are as follows:

- History Year: 2015-2019

- Base Year: 2019

- Estimated Year: 2020

- Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Adoptive Cell Therapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CAR-T
1.4.3 TCR-T
1.4.4 NK
1.4.5 TIL
1.5 Market by Application
1.5.1 Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Lymphoma
1.5.3 Leukemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Adoptive Cell Therapy Market Perspective (2015-2026)
2.2 Adoptive Cell Therapy Growth Trends by Regions
2.2.1 Adoptive Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adoptive Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Adoptive Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Adoptive Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Market Size
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adoptive Cell Therapy Market Concentration Ratio
3.2.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2019
3.3 Adoptive Cell Therapy Key Players Head office and Area Served
3.4 Key Players Adoptive Cell Therapy Product Solution and Service
3.5 Date of Enter into Adoptive Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Adoptive Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Adoptive Cell Therapy Market Size by Application (2015-2020)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2015-2020)
6.2 Adoptive Cell Therapy Key Players in North America (2019-2020)
6.3 North America Adoptive Cell Therapy Market Size by Type (2015-2020)
6.4 North America Adoptive Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2015-2020)
7.2 Adoptive Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Adoptive Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Adoptive Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China Adoptive Cell Therapy Market Size (2015-2020)
8.2 Adoptive Cell Therapy Key Players in China (2019-2020)
8.3 China Adoptive Cell Therapy Market Size by Type (2015-2020)
8.4 China Adoptive Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adoptive Cell Therapy Market Size (2015-2020)
9.2 Adoptive Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Adoptive Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Adoptive Cell Therapy Market Size by Application (2015-2020)
10 South Korea
10.1 South Korea Adoptive Cell Therapy Market Size (2015-2020)
10.2 Adoptive Cell Therapy Key Players in South Korea (2019-2020)
10.3 South Korea Adoptive Cell Therapy Market Size by Type (2015-2020)
10.4 South Korea Adoptive Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India Adoptive Cell Therapy Market Size (2015-2020)
11.2 Adoptive Cell Therapy Key Players in India (2019-2020)
11.3 India Adoptive Cell Therapy Market Size by Type (2015-2020)
11.4 India Adoptive Cell Therapy Market Size by Application (2015-2020)
12 Key Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Novartis Business Overview and Its Total Revenue
12.1.3 Novartis Adoptive Cell Therapy Introduction
12.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2015-2020))
12.1.5 Novartis Recent Development
12.2 Juno
12.2.1 Juno Company Details
12.2.2 Juno Business Overview and Its Total Revenue
12.2.3 Juno Adoptive Cell Therapy Introduction
12.2.4 Juno Revenue in Adoptive Cell Therapy Business (2015-2020)
12.2.5 Juno Recent Development
12.3 Kite
12.3.1 Kite Company Details
12.3.2 Kite Business Overview and Its Total Revenue
12.3.3 Kite Adoptive Cell Therapy Introduction
12.3.4 Kite Revenue in Adoptive Cell Therapy Business (2015-2020)
12.3.5 Kite Recent Development
12.4 Adaptimmune
12.4.1 Adaptimmune Company Details
12.4.2 Adaptimmune Business Overview and Its Total Revenue
12.4.3 Adaptimmune Adoptive Cell Therapy Introduction
12.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020)
12.4.5 Adaptimmune Recent Development
12.5 Fibrocell
12.5.1 Fibrocell Company Details
12.5.2 Fibrocell Business Overview and Its Total Revenue
12.5.3 Fibrocell Adoptive Cell Therapy Introduction
12.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020)
12.5.5 Fibrocell Recent Development
12.6 Lineage Cell Therapeutics
12.6.1 Lineage Cell Therapeutics Company Details
12.6.2 Lineage Cell Therapeutics Business Overview and Its Total Revenue
12.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
12.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020)
12.6.5 Lineage Cell Therapeutics Recent Development
12.7 BioTime
12.7.1 BioTime Company Details
12.7.2 BioTime Business Overview and Its Total Revenue
12.7.3 BioTime Adoptive Cell Therapy Introduction
12.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2015-2020)
12.7.5 BioTime Recent Development
12.8 Vericel Corporation
12.8.1 Vericel Corporation Company Details
12.8.2 Vericel Corporation Business Overview and Its Total Revenue
12.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
12.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020)
12.8.5 Vericel Corporation Recent Development
12.9 Regeneus
12.9.1 Regeneus Company Details
12.9.2 Regeneus Business Overview and Its Total Revenue
12.9.3 Regeneus Adoptive Cell Therapy Introduction
12.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020)
12.9.5 Regeneus Recent Development
12.10 Anhui Anke Biotechnology
12.10.1 Anhui Anke Biotechnology Company Details
12.10.2 Anhui Anke Biotechnology Business Overview and Its Total Revenue
12.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
12.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020)
12.10.5 Anhui Anke Biotechnology Recent Development
12.11 Cellectis
10.11.1 Cellectis Company Details
10.11.2 Cellectis Business Overview and Its Total Revenue
10.11.3 Cellectis Adoptive Cell Therapy Introduction
10.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020)
10.11.5 Cellectis Recent Development
12.12 NantKwest
10.12.1 NantKwest Company Details
10.12.2 NantKwest Business Overview and Its Total Revenue
10.12.3 NantKwest Adoptive Cell Therapy Introduction
10.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020)
10.12.5 NantKwest Recent Development
12.13 SorrentoTherapeutics
10.13.1 SorrentoTherapeutics Company Details
10.13.2 SorrentoTherapeutics Business Overview and Its Total Revenue
10.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
10.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020)
10.13.5 SorrentoTherapeutics Recent Development
12.14 Bellicum
10.14.1 Bellicum Company Details
10.14.2 Bellicum Business Overview and Its Total Revenue
10.14.3 Bellicum Adoptive Cell Therapy Introduction
10.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020)
10.14.5 Bellicum Recent Development
13 Analyst's Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details
List of Tables
Table 1. Adoptive Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adoptive Cell Therapy Revenue
Table 3. Ranking of Global Top Adoptive Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CAR-T
Table 6. Key Players of TCR-T
Table 7. Key Players of NK
Table 8. Key Players of TIL
Table 9. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Adoptive Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Adoptive Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Adoptive Cell Therapy Market Share by Regions (2015-2020)
Table 13. Global Adoptive Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Adoptive Cell Therapy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Adoptive Cell Therapy Market Growth Strategy
Table 19. Main Points Interviewed from Key Adoptive Cell Therapy Players
Table 20. Global Adoptive Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Adoptive Cell Therapy Market Share by Players (2015-2020)
Table 22. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019)
Table 23. Global Adoptive Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Adoptive Cell Therapy Product Solution and Service
Table 26. Date of Enter into Adoptive Cell Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Adoptive Cell Therapy Market Size Share by Type (2015-2020)
Table 30. Global Adoptive Cell Therapy Revenue Market Share by Type (2021-2026)
Table 31. Global Adoptive Cell Therapy Market Size Share by Application (2015-2020)
Table 32. Global Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Adoptive Cell Therapy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 36. North America Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 38. North America Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 40. Europe Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 42. Europe Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 44. Europe Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 46. China Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 48. China Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 49. China Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 50. China Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 51. China Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 52. Japan Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 54. Japan Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 56. Japan Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 58. South Korea Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 59. South Korea Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 60. South Korea Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 61. South Korea Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 62. South Korea Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 63. South Korea Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 64. India Key Players Adoptive Cell Therapy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Adoptive Cell Therapy Market Share (2019-2020)
Table 66. India Adoptive Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 67. India Adoptive Cell Therapy Market Share by Type (2015-2020)
Table 68. India Adoptive Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 69. India Adoptive Cell Therapy Market Share by Application (2015-2020)
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Product
Table 73. Novartis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 74. Novartis Recent Development
Table 75. Juno Company Details
Table 76. Juno Business Overview
Table 77. Juno Product
Table 78. Juno Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 79. Juno Recent Development
Table 80. Kite Company Details
Table 81. Kite Business Overview
Table 82. Kite Product
Table 83. Kite Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 84. Kite Recent Development
Table 85. Adaptimmune Company Details
Table 86. Adaptimmune Business Overview
Table 87. Adaptimmune Product
Table 88. Adaptimmune Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 89. Adaptimmune Recent Development
Table 90. Fibrocell Company Details
Table 91. Fibrocell Business Overview
Table 92. Fibrocell Product
Table 93. Fibrocell Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 94. Fibrocell Recent Development
Table 95. Lineage Cell Therapeutics Company Details
Table 96. Lineage Cell Therapeutics Business Overview
Table 97. Lineage Cell Therapeutics Product
Table 98. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 99. Lineage Cell Therapeutics Recent Development
Table 100. BioTime Company Details
Table 101. BioTime Business Overview
Table 102. BioTime Product
Table 103. BioTime Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 104. BioTime Recent Development
Table 105. Vericel Corporation Business Overview
Table 106. Vericel Corporation Product
Table 107. Vericel Corporation Company Details
Table 108. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 109. Vericel Corporation Recent Development
Table 110. Regeneus Company Details
Table 111. Regeneus Business Overview
Table 112. Regeneus Product
Table 113. Regeneus Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 114. Regeneus Recent Development
Table 115. Anhui Anke Biotechnology Company Details
Table 116. Anhui Anke Biotechnology Business Overview
Table 117. Anhui Anke Biotechnology Product
Table 118. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 119. Anhui Anke Biotechnology Recent Development
Table 120. Cellectis Company Details
Table 121. Cellectis Business Overview
Table 122. Cellectis Product
Table 123. Cellectis Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 124. Cellectis Recent Development
Table 125. NantKwest Company Details
Table 126. NantKwest Business Overview
Table 127. NantKwest Product
Table 128. NantKwest Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 129. NantKwest Recent Development
Table 130. SorrentoTherapeutics Company Details
Table 131. SorrentoTherapeutics Business Overview
Table 132. SorrentoTherapeutics Product
Table 133. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 134. SorrentoTherapeutics Recent Development
Table 135. Bellicum Company Details
Table 136. Bellicum Business Overview
Table 137. Bellicum Product
Table 138. Bellicum Revenue in Adoptive Cell Therapy Business (2015-2020) (Million US$)
Table 139. Bellicum Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2020 VS 2026
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Adoptive Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Adoptive Cell Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Adoptive Cell Therapy Market Share by Players in 2019
Figure 15. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cell Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2019
Figure 17. North America Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. South Korea Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Adoptive Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 25. Juno Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 27. Kite Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 29. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 31. Fibrocell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 33. Lineage Cell Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 35. BioTime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 37. Vericel Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 39. Regeneus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 41. Anhui Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 43. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 45. NantKwest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 47. SorrentoTherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 49. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs